SEARCH

SEARCH BY CITATION

References

  • 1
    Thwaites BC, Bose M. Very low calorie diets and pre-fasting prolonged QT interval. A hidden potential danger. West Indian Med J 1992; 41: 169171.
  • 2
    Swenne I, Larsson PT. Heart risk associated with weight loss in anorexia nervosa and eating disorders: risk factors for QTc interval prolongation and dispersion. Acta Paediatr 1999; 88: 304309.
  • 3
    Nagy D, DeMeersman R, Gallagher D, Pietrobelli A, Zion AS, Daly D, Heymsfield SB. QTc interval (cardiac repolarization): lengthening after meals. Obes Res 1997; 5: 531537.
  • 4
    Hulhoven R, Rosillon D, Bridson WE, Meeus MA, Salas E, Stockis A. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study. Clin Ther 2008; 30: 260270.
  • 5
    Bloomfield D, Kost J, Ghosh K, Hreniuk D, Hickey L, Guitierrez M, Gottesdiener K, Wagner J. The effect of moxifloxacin on QTc and implications for the design of thorough QT studies. Clin Pharmacol Ther 2008; 84: 475480.
  • 6
    Scott EM, Greenwood JP, Vacca G, Stoker JB, Gilbey SG, Mary D. Carbohydrate ingestion, with transient endogenous insulinaemia, produces both sympathetic activation and vasodilatation in normal humans. Clin Sci 2002; 102: 523529.
  • 7
    Lu C, Zou X, Orr WC, Chen JDZ. Postprandial changes of sympathovagal balance measured by heart rate variability. Dig Dis Sci 1999; 44: 857861.
  • 8
    Taubel J, Wong AH, Naseem A, Ferber G, Camm AJ. Shortening of the QT interval after food can be used to demonstrate assay sensitivity in thorough QT studies. J Clin Pharmacol 2011 [Epub ahead of print].
  • 9
    Widerlov E, Jostell K, Claesson L, Odlind E, Keisu M, Freyschuss U. Influence of food intake on electrocardiograms of healthy male volunteers. Eur J Clin Pharmacol 1999; 55: 619624.
  • 10
    Gastaldelli FA, Emdin M, Conforti F, Camastra S, Ferrannini E. Insulin prolongs the QTc interval in humans. Am J Physiol Regul Integr Comp Physiol 2000; 279: R20222025.
  • 11
    Malik M. Problems of heart rate correction in assessment of drug-induced QT interval prolongation. J Cardiovasc Electrophysiol 2001; 12: 411420.
  • 12
    Wahren J, Ekbery K, Jornvall H. C-peptide and neuropathy in type 1 diabetes. Immunol Endocr Metab Agents Med Chem 2007; 7: 6977.
  • 13
    R Development Core Team. 2011). R: a language and environment for statistical computing [online]. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, Available at http://www.R-project.org/ (last accessed May 2012).
  • 14
    ICH Harmonized Tripartite Guideline E14. The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for nonantiarrhythmic drugs. International Conference on Harmonization, Step 4, Guideline, EMEA, CHMP/ICH/2/04, 2005.
  • 15
    Dixon R, Job S, Oliver R, Tompson D, Wright JG, Maltby K, Lorch U, Taubel J. Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects. Br J Clin Pharmacol 2008; 66: 396404. Epub 2008 Jul 23.
  • 16
    Taubel J, Naseem A, Harada T, Wang D, Arezina R, Lorch U, Camm AJ. Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers. Br J Clin Pharmacol 2009; 69: 391400.
  • 17
    Demolis JL, Kubitza D, Tenneze L, Funck-Brentano C. Effect of a single oral dose of moxifloxacin (400mg and 800mg) on ventricular repolarization in healthy subjects. Clin Pharmacol Ther 2000; 68: 658666.
  • 18
    Florian J, Tornøe C, Brundage R, Parekh A, Garnett C. Population pharmacokinetic and concentration-QTc models for moxifloxacin: pooled analysis of 20 thorough QT studies. J Clin Pharmacol 2011; 51: 11521162. Epub 2011 Jan 12.
  • 19
    ICH Harmonized Tripartite Guideline E14. The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. International conference on harmonisation, E14 Implementation and working group, Question and Answers, 2008.
  • 20
    Johansson BL, Borg K, Fernqvist-Forbes E, Odergren T, Remahl S, Wahren J. C-peptide improves autonomic nerve function in IDDM patients. Diabetologia 1996; 39: 687695.
  • 21
    Browne KF, Zipes DP, Heger JJ, Prystowsky EN. Influence of the autonomic nervous system on the Q-T interval in man. Am J Cardiol 1982; 50: 10991103.
  • 22
    Suys B, Heuten S, De Wolf D, Verherstraeten M, de Beeck LO, Matthys D, Vrints C, Rooman R. Glycemia and corrected QT interval prolongation in young type 1 diabetic patients: what is the relation? Diabetes Care 2006; 2: 427429.
  • 23
    Dekker JM, Crow RS, Hannan PJ, Schouten EG, AR F, Study ARIC. Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in Black and White middle-aged men and women: the ARIC study. J Am Coll Cardiol 2004; 18: 565571.